Kriya Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kriya Therapeutics's estimated annual revenue is currently $32.9M per year.(i)
  • Kriya Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Kriya Therapeutics has 212 Employees.(i)
  • Kriya Therapeutics grew their employee count by -13% last year.

Kriya Therapeutics's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
CMOReveal Email/Phone
3
SVP, Technical DevelopmentReveal Email/Phone
4
VP IPReveal Email/Phone
5
VP, Head Corporate CommunicationsReveal Email/Phone
6
VP, Research and Development, NeurologyReveal Email/Phone
7
SVP, Strategic Planning and IntegrationReveal Email/Phone
8
VP, Analytical DevelopmentReveal Email/Phone
9
VP Research and Development Metabolic DiseaseReveal Email/Phone
10
SVP, Technical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Kriya Therapeutics?

Kriya Therapeutics is a transformative gene therapy company with the intent to expand gene therapy to broader disease indications leveraging in house manufacturing capabilities and novel therapeutic designs. Our mission is to identify, develop, and bring to market high-impact therapies that have the potential to improve the lives of patients with prevalent and severe chronic diseases. We target conditions where the underlying biology is well-understood, rationally designing one-time gene therapies to durably express therapeutic proteins within the appropriate human tissues. Our team has deep expertise in the field and includes former senior leadership from pioneering gene therapy companies and academic institutions. We use algorithmic tools, scalable infrastructure, and proprietary technology to optimize the efficacy and durability of our gene therapies – with a goal of transforming the treatment paradigm for some of the most serious and widespread diseases.

keywords:N/A

N/A

Total Funding

212

Number of Employees

$32.9M

Revenue (est)

-13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34M213N/AN/A
#2
$32.1M213-4%$109.8M
#3
$29.9M214-15%$74.2M
#4
$33.1M21528%N/A
#5
$33.3M221-6%$34.8M